Sotatercept FDA approval follows trial at Norton Pulmonary Specialists

Sotatercept was recently approved by the Food and Drug Administration (FDA) to treat adults with pulmonary arterial hypertension (PAH) after completing a Phase 3 clinical trial at Norton Pulmonary Specialists and other leading pulmonary hypertension [...]

View more

A case study comparing a pulmonology consult with ChatGPT results

Artificial intelligence (AI) like ChatGPT can compose essays or emails, write computer code, even generate art, but how well can it manage complex patient care? A team that included Norton Healthcare researchers decided to find […]

View more

April 2024 Norton Medical Group New Providers

John T. Garner, M.D. Hospital Medicine Ishan J. Parikh, D.O. Hospital Medicine Aleksandr Pevtsov, D.O. Emergency Medicine Elizabeth Fahey, PA-C Orthopedic Hand Surgery Amy Seldon, PA-C Emergency Medicine Gregory A. Hart, APRN Emergency Medicine Amy […]

View more

Optimizing general health and well-being through ‘prehab’ can improve surgical outcomes

Prehabilitation, or “prehab,” refers to optimizing general health and well-being before surgery to improve surgical outcomes. Prehab takes a multidisciplinary approach, focusing on strength and aerobic exercises, nutrition, smoking cessation, alcohol reduction, and psychological factors […]

View more

Phase 1 cystic fibrosis trial studying novel enzyme replacement therapy in adults

Patients 18 years of age and older with cystic fibrosis now have an option of participating in a Phase 1 trial of a novel, broad-spectrum, orally delivered enzyme replacement therapy for cystic fibrosis (CF). The [...]

View more

Sciatic neuropathy case study: 4-centimeter tumor discovered on sciatic nerve

The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. [...]

View more

March 2024 Norton Medical Group new providers

Paul A. Kniery, M.D. Internal Medicine Stephen Love, M.D. Behavioral Medicine Sarah A. Mayfield, M.D. Internal Medicine Emmanuel A. Nidhiry, M.D. Medical Oncology and Hematology Anupama Raghuram, M.D. Infectious Diseases Elizabeth Fahey, PA-C Hand Surgery […]

View more

Updated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s

In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]

View more

Norton Louisville Arm & Hand becomes Norton Arm & Hand Institute

Norton Arm & Hand Institute is the new name for Norton Louisville Arm & Hand, as of March 1, 2024. The goal of Norton Arm & Hand Institute is to be a destination program by […]

View more

Open-access, peer-reviewed medical journal accepting submissions

Norton Healthcare has launched a new, open-access medical journal to promote the sharing of innovation and ideas from the laboratory, the bedside and everyday practice. Norton Healthcare Medical Journal welcomes original articles related to medicine, […]

View more

Antimicrobial stewardship

The Norton Healthcare Antimicrobial Stewardship Program was recognized this year as the first and only antimicrobial stewardship center of excellence in the United States by the British Society of Antimicrobial Chemotherapy. The international collaboration is […]

View more

Norton Cancer Institute enrolling patients for gotistobart (ONC-392) Phase 3 trial

Norton Cancer Institute is enrolling metastatic lung cancer patients in a Phase 3 clinical trial to test a promising new anti-CLTA-4 antibody, gotistobart (ONC-392). The study will test whether gotistobart is more effective than the [...]

View more

Search our entire site.